[
    {
        "question_id": "1_B_2226",
        "new_question_id": "4046",
        "question_type": "0",
        "category": "3",
        "concept_id_link": "0",
        "notes_id_link": "1_1692",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Metformin",
            "Sitagliptin",
            "Pioglitazone",
            "Insulin",
            "Gliclizide",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 62-year-old gentleman with a background of myocardial infarction, congestive heart failure and chronic obstructive pulmonary disease attends for a diabetes review at his GP.  He has recently been diagnosed with type 2 diabetes mellitus and despite a trial of lifestyle modifications his HbA1c is 56 mmol/mol.  His GP decides to commence drug treatment.<br /><br />Which of the following drugs would be contraindicated for this patient?",
            "",
            ""
        ],
        "answers": [
            "3",
            "",
            ""
        ],
        "notes": [
            "Pioglitazone can cause fluid retention and is therefore contraindicated in patients with heart failure.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 62-year-old gentleman with a background of myocardial infarction, congestive heart failure and chronic obstructive pulmonary disease attends for a diabetes review at his GP.  He has recently been diagnosed with type 2 diabetes mellitus and despite a trial of lifestyle modifications his HbA1c is 56 mmol/mol.  His GP decides to commence drug treatment.<br /><br />Which of the following drugs would be contraindicated for this patient?",
        "correct_answer": "3",
        "question_notes": "Pioglitazone can cause fluid retention and is therefore contraindicated in patients with heart failure.",
        "answer_order": "3",
        "answer": "3",
        "title": "Diabetes mellitus: management of type 2",
        "body": "NICE updated its guidance on the management of type 2 diabetes mellitus (T2DM) in 2022. This update reflected the advances in drug therapy and improved evidence regarding newer therapies such as SGLT-2 inhibitors.<br /><br /><div class='alert alert-warning'>It's worthwhile thinking of the average patient who is taking metformin for T2DM, you can titrate up metformin and encourage lifestyle changes to aim for a HbA1c of <span class=\"concept\" data-cid=\"9108\">48 mmol/mol</span> (6.5%), but should only add a second drug if the HbA1c rises to <span class=\"concept\" data-cid=\"9109\">58 mmol/mol</span> (7.5%)<br /></div><br /><br />Dietary advice<br /><ul><li>encourage high fibre, low glycaemic index sources of carbohydrates</li><li>include low-fat dairy products and oily fish</li><li>control the intake of foods containing saturated fats and trans fatty acids</li><li>limited substitution of sucrose-containing foods for other carbohydrates is allowable, but care should be taken to avoid excess energy intake</li><li>discourage the use of foods marketed specifically at people with diabetes</li><li>initial target weight loss in an overweight person is 5-10%</li></ul><br /><br /><h5 class='notes-heading'>HbA1c targets</h5><br />This is an area which has changed in 2015<br /><ul><li>individual targets should be agreed with patients to encourage motivation</li><li>HbA1c should be checked every 3-6 months until stable, then 6 monthly</li><li>NICE encourage us to consider relaxing targets on <i>'a case-by-case basis, with particular consideration for people who are older or frail, for adults with type 2 diabetes'</i></li><li>in 2015 the guidelines changed so HbA1c targets are now dependent on treatment:</li></ul><br /><h6 class='notes-subheading'>Lifestyle or single-drug treatment</h6><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th>Management of T2DM</th><th>HbA1c target</th></tr></thead><tbody><tr><td>Lifestyle</td><td><span class=\"concept\" data-cid=\"9108\">48 mmol/mol</span> (6.5%)</td></tr><tr><td>Lifestyle + metformin</td><td><span class=\"concept\" data-cid=\"9108\">48 mmol/mol</span> (6.5%)</td></tr><tr><td>Includes any drug which may cause hypoglycaemia (e.g. lifestyle + sulfonylurea)</td><td>53 mmol/mol (7.0%)</td></tr></tbody></table></div><br />Practical examples<br /><ul><li>a patient is newly diagnosed with HbA1c and wants to try lifestyle treatment first. You agree on a target of 48 mmol/mol (6.5%)</li><li>you review a patient 6 months after starting metformin. His HbA1c is 51 mmol/mol (6.8%). You increase his metformin from 500mg bd to 500mg tds and reinforce lifestyle factors</li></ul><br /><h6 class='notes-subheading'>Patient already on treatment</h6><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid2\" ><thead><tr><th>Management of T2DM</th><th>HbA1c target</th></tr></thead><tbody><tr><td>Already on one drug, but HbA1c has risen to <span class=\"concept\" data-cid=\"9109\">58 mmol/mol</span> (7.5%)</td><td>53 mmol/mol (7.0%)</td></tr></tbody></table></div><br /><h5 class='notes-heading'>Initial drug therapy</h5><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd928b.png'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd928.png'/></a></td></tr><tr><td valign='top' align='left'></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd928b.png'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><div class='imagetext'>Simplified initial management of type 2 diabetes mellitus</div><br /><span class=\"concept\" data-cid=\"9107\">Metformin remains the first-line drug</span> of choice in type 2 diabetes mellitus.<br /><ul><li>metformin should be titrated up slowly to minimise the possibility of gastrointestinal upset</li><li>if standard-release metformin is not tolerated then modified-release metformin should be trialled</li></ul><br /><span class=\"concept\" data-cid=\"11772\">SGLT-2 inhibitors</span><br /><ul><li>should also be given in addition to metformin if any of the following apply:<ul><li>the patient has a high risk of developing cardiovascular disease (CVD, e.g. QRISK \u2265 10%)</li><li>the patient has established CVD</li><li>the patient has chronic heart failure</li></ul></li><li><span class=\"concept\" data-cid=\"11773\">metformin should be established and titrated up before introducing the SGLT-2 inhibitor</span></li><li><span class=\"concept\" data-cid=\"11774\">SGLT-2 inhibitors should also be started at any point if a patient develops CVD (e.g. is diagnosed with ischaemic heart disease), a QRISK \u2265 10% or chronic heart failure</span></li></ul><br />If metformin is contraindicated<br /><ul><li>if the patient has a risk of CVD, established CVD or chronic heart failure:<ul><li><span class=\"concept\" data-cid=\"11775\">SGLT-2 monotherapy</span></li></ul></li><li>if the patient doesn't have a risk of CVD, established CVD or chronic heart failure:<ul><li><span class=\"concept\" data-cid=\"11776\">DPP-4 inhibitor or pioglitazone or a sulfonylurea</span></li><li>SGLT-2 may be used if certain NICE criteria are met</li></ul></li></ul><br /><br /><h5 class='notes-heading'>Further drug therapy if HbA1c targets are not met</h5><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd929b.png'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd929.png'/></a></td></tr><tr><td valign='top' align='left'></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd929b.png'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><div class='imagetext'>Simplified further management of type 2 diabetes mellitus if HbA1c targets are not met</div><br />If the HbA1c has risen to 58 mmol/mol (7.5%) then further treatment is indicated. Given the large number of drug therapy options, medication choices depend on individual clinical circumstances (comorbidities, contraindications, weight) and patient preference.<br /><br /><h6 class='notes-subheading'>Second-line therapy</h6><br /><span class=\"concept\" data-cid=\"11777\">Dual therapy - add one of the following:</span><br /><ul><li>metformin + DPP-4 inhibitor</li><li>metformin + pioglitazone</li><li>metformin + sulfonylurea</li><li>metformin + SGLT-2 inhibitor (if NICE criteria met)</li></ul><br /><h6 class='notes-subheading'>Third-line therapy</h6><br /><span class=\"concept\" data-cid=\"11395\">If a patient does not achieve control on dual therapy then the following options are possible:</span><br /><ul><li>metformin + DPP-4 inhibitor + sulfonylurea</li><li>metformin  + pioglitazone + sulfonylurea</li><li>metformin + (pioglitazone or sulfonylurea or DPP-4 inhibitor) + SGLT-2 if certain NICE criteria are met</li><li>insulin-based treatment</li></ul><br /><h6 class='notes-subheading'>Further therapy</h6><br />If triple therapy is not effective or tolerated consider <span class=\"concept\" data-cid=\"11396\">switching one of the drugs for a GLP-1 mimetic</span>:<br /><ul><li>BMI \u2265 35 kg/m\u00b2 and specific psychological or other medical problems associated with obesity or</li><li>BMI < 35 kg/m\u00b2 and for whom insulin therapy would have significant occupational implications or weight loss would benefit other significant obesity-related comorbidities</li><li>only continue if there is a reduction of at least 11 mmol/mol [1.0%] in HbA1c and a weight loss of at least 3% of initial body weight in 6 months</li></ul><br />GLP-1 mimetics should only be added to insulin under specialist care<br /><br />Starting insulin<br /><ul><li>metformin should be continued. In terms of other drugs NICE advice: <i>'Review the continued need for other blood glucose-lowering therapies'</i></li><li>NICE recommend starting with human NPH insulin (isophane, intermediate-acting) taken at bed-time or twice daily according to need</li></ul><br />Practical examples<br /><ul><li>you review an established type 2 diabetic on maximum dose metformin. Her HbA1c is 55 mmol/mol (7.2%). You do not add another drug as she has not reached the threshold of 58 mmol/mol (7.5%)</li><li>a type 2 diabetic is found to have an HbA1c of 62 mmol/mol (7.8%) at annual review. They are currently on maximum dose metformin. You elect to add a sulfonylurea</li></ul><br /><br /><h5 class='notes-heading'>Risk factor modification</h5><br />Hypertension<br /><ul><li><span class=\"concept\" data-cid=\"399\"><b>blood pressure targets are the same as for patients without type 2 diabetes</b> (see table below)</span></li><li>ACE inhibitors or angiotensin II receptor blockers (ARB) are first-line<ul><li>an <span class=\"concept\" data-cid=\"11206\">ARB is preferred if the patient has a black African or African-Caribbean</span> family origin</li></ul></li></ul><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid3\" ><thead><tr><th></th><th><b>Clinic BP</b></th><th><b>ABPM / HBPM</b></th></tr></thead><tbody><tr><td><b>Age < 80 years</b></td><td>140/90 mmHg</td><td>135/85 mmHg</td></tr><tr><td><b>Age > 80 years</b></td><td>150/90 mmHg</td><td>145/85 mmHg</td></tr></tbody></table></div><br />Antiplatelets<br /><ul><li>should not be offered unless a patient has existing cardiovascular disease</li></ul><br />Lipids<br /><ul><li>following the 2014 NICE lipid modification guidelines only patients with a 10-year cardiovascular risk > 10% (using QRISK2) should be offered a statin. The first-line statin of choice is atorvastatin 20mg on</li></ul><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd915b.png'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd915.png'/></a></td></tr><tr><td valign='top' align='left'></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd915b.png'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><div class='imagetext'>Graphic showing choice of statin.</div>",
        "notes_hash": "ca06d8c38ddc0f626be19075164b9bce",
        "knowledge_graph_node_id_link": 10924,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "6950",
        "up_votes": "64",
        "down_votes": "25",
        "column_array": [
            0,
            "1154",
            "515",
            "4726",
            "85",
            "470",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>SIGN</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_721\" data-linkid=\"721\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_721\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">36</span><button type=\"button\" style=\"\" id=\"link_dislike_721\" data-linkid=\"721\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_721\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">47</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.sign.ac.uk/assets/qrg116.pdf\">2010 Management of diabetes</a></td></tr></table><br><br><table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_457\" data-linkid=\"457\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_457\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">34</span><button type=\"button\" style=\"\" id=\"link_dislike_457\" data-linkid=\"457\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_457\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">43</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/CG181/chapter/1-Recommendations\">2014 Lipid modification guidelines</a></td></tr></table><br><br><table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_911\" data-linkid=\"911\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_911\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">56</span><button type=\"button\" style=\"\" id=\"link_dislike_911\" data-linkid=\"911\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_911\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">54</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng28/chapter/Recommendations\">2022 Type 2 diabetes guidelines</a></td></tr></table><br><br><table style='width:100%'><tr><td>7 minute medics</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1395\" data-linkid=\"1395\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1395\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">44</span><button type=\"button\" style=\"\" id=\"link_dislike_1395\" data-linkid=\"1395\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1395\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">32</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://anchor.fm/7minutemedics/episodes/Episode-2---Type-2-Diabetes-e2ebql\">Basics of type 2 diabetes - podcast</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/4Y7wdX7iEAY\" data-description=\"Type 2 diabetes agents and their mechanism of action\" data-upvotes=\"51\" data-downvotes=\"6\" data-media=\"694\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/4Y7wdX7iEAY/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/4Y7wdX7iEAY\" data-description=\"Type 2 diabetes agents and their mechanism of action\" data-upvotes=\"51\" data-downvotes=\"6\" data-media=\"694\">Type 2 diabetes agents and their mechanism of action</a></td></tr><tr><td><span ><small>Brandl's Basics - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1195\" data-mediaid=\"1195\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1195\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">51</span><button type=\"button\" style=\"\" id=\"media_dislike_1195\" data-mediaid=\"1195\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1195\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">6</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/APHeDOkJKQ0\" data-description=\" Pharmacology of drugs used to treat type 2 diabetes\" data-upvotes=\"9\" data-downvotes=\"6\" data-media=\"693\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/APHeDOkJKQ0/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/APHeDOkJKQ0\" data-description=\" Pharmacology of drugs used to treat type 2 diabetes\" data-upvotes=\"9\" data-downvotes=\"6\" data-media=\"693\"> Pharmacology of drugs used to treat type 2 diabetes</a></td></tr><tr><td><span ><small>Brandl's Basics - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1194\" data-mediaid=\"1194\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1194\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">9</span><button type=\"button\" style=\"\" id=\"media_dislike_1194\" data-mediaid=\"1194\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1194\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">6</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/W0KPwTy0W9k\" data-description=\"Diabetes Type II Pathophysiology\" data-upvotes=\"4\" data-downvotes=\"4\" data-media=\"400\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/W0KPwTy0W9k/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/W0KPwTy0W9k\" data-description=\"Diabetes Type II Pathophysiology\" data-upvotes=\"4\" data-downvotes=\"4\" data-media=\"400\">Diabetes Type II Pathophysiology</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_685\" data-mediaid=\"685\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_685\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">4</span><button type=\"button\" style=\"\" id=\"media_dislike_685\" data-mediaid=\"685\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_685\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">4</span></td></tr></table>",
        "comment_count": 6,
        "concepts_for_notes": {
            "9108": {
                "concept_text": "The standard HbA1c target in type 2 diabetes mellitus is 48 mmol/mol",
                "concept_percentile": "81"
            },
            "11395": {
                "concept_text": "TD2M already on 2 drugs - if HbA1c > 58 mmol/mol then one of the following should be offered:\n   - metformin + DPP-4 inhibitor + sulfonylurea\n   - metformin  + pioglitazone + sulfonylurea\n   - metformin + (pioglitazone or sulfonylurea or DPP-4 inhibitor) + SGLT-2 if certain NICE criteria are met\n   - insulin-based treatment",
                "concept_percentile": "73"
            },
            "11396": {
                "concept_text": "TD2M: if a triple combination of drugs has failed to reduce HbA1c then switching one of the drugs for a GLP-1 mimetic is recommended, particularly if the BMI > 35",
                "concept_percentile": "76"
            },
            "11772": {
                "concept_text": "SGLT-2 inhibitors should be used in addition to metformin as initial therapy for T2DM if CVD, high-risk of CVD or chronic heart failure",
                "concept_percentile": "65"
            },
            "11773": {
                "concept_text": "If starting an SGLT-2 as initial therapy for T2DM then ensure metformin is titrated up first",
                "concept_percentile": "91"
            },
            "11774": {
                "concept_text": "In patients with T2DM, SGLT-2 should be introduced at any point they develop CVD, a high risk of CVD or chronic heart failure",
                "concept_percentile": "66"
            },
            "11775": {
                "concept_text": "T2DM initial therapy: if metformin is contraindicated + patient has a risk of CVD, established CVD or chronic heart failure --> SGLT-2 monotherapy",
                "concept_percentile": "88"
            },
            "11776": {
                "concept_text": "T2DM initial therapy: if metformin is contraindicated (and no risk of CVD, established CVD or chronic heart failure) --> choice of DPP-4 inhibitor or Pioglitazone or Sulfonylurea or even SGLT-2 (if NICE criteria met)",
                "concept_percentile": "89"
            },
            "11777": {
                "concept_text": "T2DM on metformin, if HbA1c has risen to 58 mmol/mol then one of the following should be offered depending on the individual clinical scenario:\n   - DPP-4 inhibitor\n   - pioglitazone\n   - sulfonylurea\n   - SGLT-2 inhibitor (if NICE criteria met)",
                "concept_percentile": "74"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_1773",
        "new_question_id": "6380",
        "question_type": "0",
        "category": "2",
        "concept_id_link": "0",
        "notes_id_link": "1_2104",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Right sensorineural hearing loss",
            "Right conductive hearing loss",
            "Bilateral mixed hearing loss",
            "Right mixed hearing loss",
            "Spurious results - need to repeat",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 41-year-old complains of some difficulties with his hearing which have got gradually worse over the past few weeks. An audiogram is arranged:<br /><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd102b.png'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd102.png'/></a></td></tr><tr><td valign='top' align='left'></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd102b.png'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><br />What does the audiogram show?",
            "",
            ""
        ],
        "answers": [
            "2",
            "",
            ""
        ],
        "notes": [
            "",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 41-year-old complains of some difficulties with his hearing which have got gradually worse over the past few weeks. An audiogram is arranged:<br /><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd102b.png'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd102.png'/></a></td></tr><tr><td valign='top' align='left'></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd102b.png'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><br />What does the audiogram show?",
        "correct_answer": "2",
        "question_notes": "",
        "answer_order": "2",
        "answer": "2",
        "title": "Audiograms",
        "body": "Audiograms are usually the first-line investigation that is performed when a patient complains of hearing difficulties. They are relatively easy to interpret as long as some simple rules are followed:<br /><ul><li>anything above the 20dB line is essentially normal (marked in green on the audiogram below)</li><li>in sensorineural hearing loss both air and bone conduction are impaired</li><li>in conductive hearing loss only air conduction is impaired</li><li>in mixed hearing loss both air and bone conduction are impaired, with air conduction often being 'worse' than bone</li></ul> <br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd541b.png'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd541.png'/></a></td></tr><tr><td valign='top' align='left'></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd541b.png'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><div class='imagetext'>This audiogram is essentially normal. Note all the values are above the 20dB line, highlighted in green on this image</div>",
        "notes_hash": "05be5e0c577288fe9c2ba0fd7f903136",
        "knowledge_graph_node_id_link": 0,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "6087",
        "up_votes": "49",
        "down_votes": "23",
        "column_array": [
            0,
            "1482",
            "3867",
            "341",
            "162",
            "234",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Hearing Link</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_307\" data-linkid=\"307\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_307\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">6</span><button type=\"button\" style=\"\" id=\"link_dislike_307\" data-linkid=\"307\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_307\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">12</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"http://www.hearinglink.org/your-hearing/hearing-tests-audiograms/what-do-different-audiograms-look-like/\">What do different Audiograms look like?</a></td></tr></table><br><br><table style='width:100%'><tr><td>Clinical Junior</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_47\" data-linkid=\"47\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_47\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">14</span><button type=\"button\" style=\"\" id=\"link_dislike_47\" data-linkid=\"47\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_47\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">9</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"http://clinicaljunior.com/entaudiododdi.html\">How to Read an Audiogram</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/YeQo-lbozHM\" data-description=\"Common Audiograms in ENT\" data-upvotes=\"51\" data-downvotes=\"6\" data-media=\"681\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/YeQo-lbozHM/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/YeQo-lbozHM\" data-description=\"Common Audiograms in ENT\" data-upvotes=\"51\" data-downvotes=\"6\" data-media=\"681\">Common Audiograms in ENT</a></td></tr><tr><td><span ><small>Individual - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1177\" data-mediaid=\"1177\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1177\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">51</span><button type=\"button\" style=\"\" id=\"media_dislike_1177\" data-mediaid=\"1177\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1177\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">6</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/bP-nJp3yBK4\" data-description=\"How to Read an Audiogram\" data-upvotes=\"0\" data-downvotes=\"1\" data-media=\"490\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/bP-nJp3yBK4/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/bP-nJp3yBK4\" data-description=\"How to Read an Audiogram\" data-upvotes=\"0\" data-downvotes=\"1\" data-media=\"490\">How to Read an Audiogram</a></td></tr><tr><td><span ><small>Individual - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_857\" data-mediaid=\"857\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_857\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0</span><button type=\"button\" style=\"\" id=\"media_dislike_857\" data-mediaid=\"857\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_857\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr></table>",
        "comment_count": 9,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_294",
        "new_question_id": "1505",
        "question_type": "0",
        "category": "1",
        "concept_id_link": "193",
        "notes_id_link": "1_1173",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Bile acid sequestrant",
            "Decreases hepatic HDL synthesis",
            "Inhibits lipoprotein lipase",
            "Decreases intrinsic cholesterol synthesis",
            "Agonists of PPAR-alpha",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "What is the main mechanism of action of simvastatin?",
            "",
            ""
        ],
        "answers": [
            "4",
            "",
            ""
        ],
        "notes": [
            "The main mechanism of action of simvastatin is that it <b>decreases intrinsic cholesterol synthesis</b>. Simvastatin is a member of the statin class of drugs, which function by inhibiting the enzyme HMG-CoA reductase. This enzyme plays a crucial role in the production of cholesterol in the liver. By inhibiting this enzyme, simvastatin effectively reduces the rate at which the liver produces LDL cholesterol, thereby decreasing overall blood cholesterol levels. <br /><br />Moving on to the incorrect answers, firstly, simvastatin is not a <b>bile acid sequestrant</b>. Bile acid sequestrants are a different class of lipid-lowering drugs that work by binding to bile acids in the intestine and promoting their excretion. This results in increased conversion of cholesterol into bile acids in order to replace those lost through excretion, thus reducing serum cholesterol levels.<br /><br />Secondly, simvastatin does not <b>decrease hepatic HDL synthesis</b>. In fact, statins can slightly increase HDL levels although this is not their primary mode of action. It's important to note that increasing HDL levels is generally considered beneficial as HDL plays a role in transporting excess cholesterol from peripheral tissues back to the liver for excretion.<br /><br />Next, simvastatin does not <b>inhibit lipoprotein lipase</b>. Lipoprotein lipase is an enzyme responsible for breaking down triglycerides within very low-density lipoproteins (VLDL) and chylomicrons. Inhibitors of this enzyme would actually lead to an increase in plasma triglyceride levels.<br /><br />Lastly, simvastatin is not an <b>agonist of PPAR-alpha</b>. PPAR-alpha agonists like fibrates primarily reduce triglyceride levels and may raise HDL cholesterol but they have little effect on LDL cholesterol. Statins like simvastatin are more effective at lowering LDL cholesterol which is why they are often the first-line therapy for hypercholesterolaemia according to UK guidelines.<br />",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "What is the main mechanism of action of simvastatin?",
        "correct_answer": "4",
        "question_notes": "The main mechanism of action of simvastatin is that it <b>decreases intrinsic cholesterol synthesis</b>. Simvastatin is a member of the statin class of drugs, which function by inhibiting the enzyme HMG-CoA reductase. This enzyme plays a crucial role in the production of cholesterol in the liver. By inhibiting this enzyme, simvastatin effectively reduces the rate at which the liver produces LDL cholesterol, thereby decreasing overall blood cholesterol levels. <br /><br />Moving on to the incorrect answers, firstly, simvastatin is not a <b>bile acid sequestrant</b>. Bile acid sequestrants are a different class of lipid-lowering drugs that work by binding to bile acids in the intestine and promoting their excretion. This results in increased conversion of cholesterol into bile acids in order to replace those lost through excretion, thus reducing serum cholesterol levels.<br /><br />Secondly, simvastatin does not <b>decrease hepatic HDL synthesis</b>. In fact, statins can slightly increase HDL levels although this is not their primary mode of action. It's important to note that increasing HDL levels is generally considered beneficial as HDL plays a role in transporting excess cholesterol from peripheral tissues back to the liver for excretion.<br /><br />Next, simvastatin does not <b>inhibit lipoprotein lipase</b>. Lipoprotein lipase is an enzyme responsible for breaking down triglycerides within very low-density lipoproteins (VLDL) and chylomicrons. Inhibitors of this enzyme would actually lead to an increase in plasma triglyceride levels.<br /><br />Lastly, simvastatin is not an <b>agonist of PPAR-alpha</b>. PPAR-alpha agonists like fibrates primarily reduce triglyceride levels and may raise HDL cholesterol but they have little effect on LDL cholesterol. Statins like simvastatin are more effective at lowering LDL cholesterol which is why they are often the first-line therapy for hypercholesterolaemia according to UK guidelines.<br />",
        "answer_order": "4",
        "answer": "4",
        "title": "Statins",
        "body": "Statins <span class=\"concept\" data-cid=\"193\">inhibit the action of HMG-CoA reductase, the rate-limiting enzyme in hepatic cholesterol synthesis</span>.<br /><br />Adverse effects<br /><ul><li>myopathy: includes <span class=\"concept\" data-cid=\"9722\">myalgia</span>, myositis, rhabdomyolysis and asymptomatic raised creatine kinase. Risks factors for myopathy include advanced age, female sex, low body mass index and presence of multisystem disease such as diabetes mellitus. Myopathy is more common in lipophilic statins (simvastatin, atorvastatin) than relatively hydrophilic statins (rosuvastatin, pravastatin, fluvastatin)</li><li>liver impairment: the 2014 NICE guidelines recommend checking LFTs at baseline, 3 months and 12 months. Treatment should be discontinued if serum transaminase concentrations rise to and persist at 3 times the upper limit of the reference range</li><li>there is some evidence that statins may increase the risk of intracerebral haemorrhage in patients who've previously had a stroke. This effect is not seen in primary prevention. For this reason the Royal College of Physicians recommend avoiding statins in patients with a history of intracerebral haemorrhage</li></ul><br />Contraindications<br /><ul><li><span class=\"concept\" data-cid=\"194\">macrolides (e.g. erythromycin, clarithromycin) are an important interaction</span>. <span class=\"concept\" data-cid=\"3084\">Statins should be stopped until patients complete the course</span></li><li><span class=\"concept\" data-cid=\"3334\">pregnancy</span></li></ul><br />Who should receive a statin?<br /><ul><li>all people with established cardiovascular disease (stroke, TIA, ischaemic heart disease, peripheral arterial disease)</li><li>following the 2014 update, <span class=\"concept\" data-cid=\"5826\">NICE recommend anyone with a 10-year cardiovascular risk >= 10%</span></li><li>patients with type 2 diabetes mellitus should now be assessed using QRISK2 like other patients are, to determine whether they should be started on statins</li><li>patients with type 1 diabetes mellitus who were diagnosed more than 10 years ago OR are aged over 40 OR have established nephropathy</li></ul><br />Statins should be taken at night as this is when the majority of cholesterol synthesis takes place. This is especially true for simvastatin which has a shorter half-life than other statins.<br /><br />NICE currently recommends the following for the prevention of cardiovascular disease::<br /><ul><li><span class=\"concept\" data-cid=\"3368\">atorvastatin 20mg for primary prevention</span><ul><li><span class=\"concept\" data-cid=\"9707\">increase the dose if non-HDL has not reduced for >= 40%</span></li></ul></li><li><span class=\"concept\" data-cid=\"3368\">atorvastatin 80mg for secondary prevention</span></li></ul><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd915b.png'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd915.png'/></a></td></tr><tr><td valign='top' align='left'></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd915b.png'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><div class='imagetext'>Graphic showing choice of statin.</div>",
        "notes_hash": "8dffe0ce6a95494abf67143e132898cc",
        "knowledge_graph_node_id_link": 10836,
        "concept": "Statins inhibit HMG-CoA reductase, the rate-limiting enzyme in hepatic cholesterol synthesis",
        "concept_percentile": "41",
        "concept_colour": "rgb(255,209,0)",
        "number_attempts": "6020",
        "up_votes": "34",
        "down_votes": "27",
        "column_array": [
            0,
            "141",
            "1004",
            "1026",
            "3504",
            "345",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>RCP</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1175\" data-linkid=\"1175\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1175\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">12</span><button type=\"button\" style=\"\" id=\"link_dislike_1175\" data-linkid=\"1175\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1175\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">23</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.strokeaudit.org/SupportFiles/Documents/Guidelines/2016-National-Clinical-Guideline-for-Stroke-5t-(1).aspx\">2016 Stroke guidelines</a></td></tr></table><br><br><table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_908\" data-linkid=\"908\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_908\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">14</span><button type=\"button\" style=\"\" id=\"link_dislike_908\" data-linkid=\"908\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_908\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">14</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/CG181/chapter/1-Recommendations\">2014 Lipid modification guidelines</a></td></tr></table><br><br><table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_335\" data-linkid=\"335\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_335\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">23</span><button type=\"button\" style=\"\" id=\"link_dislike_335\" data-linkid=\"335\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_335\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">16</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng28/chapter/Recommendations\">2022 Type 2 diabetes guidelines</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Of1Aewx-zRM\" data-description=\"Drugs for hyperlipidaemia\" data-upvotes=\"9\" data-downvotes=\"1\" data-media=\"627\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/Of1Aewx-zRM/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Of1Aewx-zRM\" data-description=\"Drugs for hyperlipidaemia\" data-upvotes=\"9\" data-downvotes=\"1\" data-media=\"627\">Drugs for hyperlipidaemia</a></td></tr><tr><td><span ><small>Speed Pharmacology - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1072\" data-mediaid=\"1072\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1072\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">9</span><button type=\"button\" style=\"\" id=\"media_dislike_1072\" data-mediaid=\"1072\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1072\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr></table>",
        "comment_count": 0,
        "concepts_for_notes": {
            "193": {
                "concept_text": "Statins inhibit HMG-CoA reductase, the rate-limiting enzyme in hepatic cholesterol synthesis",
                "concept_percentile": "41"
            },
            "194": {
                "concept_text": "Statins + erythromycin/clarithromycin  - an important and common interaction",
                "concept_percentile": "52"
            },
            "3334": {
                "concept_text": "Pregnancy is a contraindication to statin therapy",
                "concept_percentile": "83"
            },
            "3368": {
                "concept_text": "Cardiovascular disease: atorvastatin 20mg for primary prevention, 80mg for secondary prevention ",
                "concept_percentile": "72"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_9475",
        "new_question_id": "2937",
        "question_type": "0",
        "category": "5",
        "concept_id_link": "8946",
        "notes_id_link": "1_1474",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Oral metronidazole",
            "Topical clindamycin",
            "Oral azithromycin",
            "Oral doxycycline",
            "Topical clotrimazole",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 33-year-old woman presents with an offensive, watery vaginal discharge. A swab is taken which shows the presence of clue cells.<br /><br />Past medical history<br /><ul><li>polycystic ovarian syndrome</li></ul><br />Current medication<br /><ul><li>Microgynon 30 asd</li><li>cetirizine 10mg od</li></ul><br />Allergies<br /><ul><li>penicillins</li><li>metronidazole</li></ul><br />Given the likely diagnosis, what is the most appropriate management?",
            "",
            ""
        ],
        "answers": [
            "2",
            "",
            ""
        ],
        "notes": [
            "The correct answer is <b>Topical clindamycin</b>. The presence of clue cells on microscopy is pathognomonic for bacterial vaginosis (BV), which is characterised by an overgrowth of anaerobic bacteria and a reduction in normal vaginal lactobacilli. Given the patient's documented allergy to metronidazole, which would typically be first-line treatment, topical clindamycin cream 2% for 7 days is the appropriate alternative treatment according to UK guidelines.<br /><br /><b>Oral metronidazole</b> would normally be the first-line treatment for bacterial vaginosis, but this patient has a documented allergy to metronidazole, making this option inappropriate and potentially dangerous.<br /><br /><b>Oral azithromycin</b> is not indicated for bacterial vaginosis. It is primarily used to treat chlamydial infection and some other sexually transmitted infections. The clinical presentation and presence of clue cells do not suggest chlamydia as the diagnosis.<br /><br /><b>Oral doxycycline</b> is not a recommended treatment for bacterial vaginosis. Like azithromycin, it is more commonly used for treating chlamydial infection and other STIs. Additionally, it would not target the anaerobic bacteria typically responsible for BV.<br /><br /><b>Topical clotrimazole</b> is an antifungal medication used to treat vaginal candidiasis. The presence of clue cells rather than pseudohyphae on microscopy, along with the description of a watery (rather than thick, white) discharge, makes candidiasis unlikely. Therefore, an antifungal would not be appropriate in this case.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 33-year-old woman presents with an offensive, watery vaginal discharge. A swab is taken which shows the presence of clue cells.<br /><br />Past medical history<br /><ul><li>polycystic ovarian syndrome</li></ul><br />Current medication<br /><ul><li>Microgynon 30 asd</li><li>cetirizine 10mg od</li></ul><br />Allergies<br /><ul><li>penicillins</li><li>metronidazole</li></ul><br />Given the likely diagnosis, what is the most appropriate management?",
        "correct_answer": "2",
        "question_notes": "The correct answer is <b>Topical clindamycin</b>. The presence of clue cells on microscopy is pathognomonic for bacterial vaginosis (BV), which is characterised by an overgrowth of anaerobic bacteria and a reduction in normal vaginal lactobacilli. Given the patient's documented allergy to metronidazole, which would typically be first-line treatment, topical clindamycin cream 2% for 7 days is the appropriate alternative treatment according to UK guidelines.<br /><br /><b>Oral metronidazole</b> would normally be the first-line treatment for bacterial vaginosis, but this patient has a documented allergy to metronidazole, making this option inappropriate and potentially dangerous.<br /><br /><b>Oral azithromycin</b> is not indicated for bacterial vaginosis. It is primarily used to treat chlamydial infection and some other sexually transmitted infections. The clinical presentation and presence of clue cells do not suggest chlamydia as the diagnosis.<br /><br /><b>Oral doxycycline</b> is not a recommended treatment for bacterial vaginosis. Like azithromycin, it is more commonly used for treating chlamydial infection and other STIs. Additionally, it would not target the anaerobic bacteria typically responsible for BV.<br /><br /><b>Topical clotrimazole</b> is an antifungal medication used to treat vaginal candidiasis. The presence of clue cells rather than pseudohyphae on microscopy, along with the description of a watery (rather than thick, white) discharge, makes candidiasis unlikely. Therefore, an antifungal would not be appropriate in this case.",
        "answer_order": "2",
        "answer": "2",
        "title": "Bacterial vaginosis",
        "body": "Bacterial vaginosis (BV) describes an overgrowth of predominately anaerobic organisms such as <span class=\"concept\" data-cid=\"310\"><i>Gardnerella vaginalis</i></span>. This leads to a consequent fall in lactic acid producing aerobic lactobacilli resulting in a raised vaginal pH.<br /><br />Whilst BV is not a sexually transmitted infection it is seen almost exclusively in sexually active women.<br /> <br />Features<br /><ul><li>vaginal discharge: 'fishy', offensive</li><li>asymptomatic in 50%</li></ul><br />Amsel's criteria for diagnosis of BV - 3 of the following 4 points should be present<br /><ul><li>thin, white homogenous discharge</li><li>clue cells on microscopy: stippled vaginal epithelial cells</li><li><span class=\"concept\" data-cid=\"5255\">vaginal pH > 4.5</span></li><li>positive whiff test (addition of potassium hydroxide results in fishy odour)</li></ul><br />Management<br /><ul><li><span class=\"concept\" data-cid=\"1679\">if the woman is asymptomatic, treatment is not usually required</span> #link33 <ul><li>e.g. picked up on a swab done for different reasons</li><li>exceptions include if a woman is undergoing a termination of pregnancy</li></ul></li><li>if symptomatic: <span class=\"concept\" data-cid=\"309\">oral metronidazole for 5-7 days</span> #link34 <ul><li>70-80% initial cure rate</li><li>relapse rate > 50% within 3 months</li><li>a single oral dose of metronidazole  2g may be used if adherence may be an issue</li><li>the BNF suggests topical metronidazole or <span class=\"concept\" data-cid=\"8946\">topical clindamycin</span> as alternatives</li></ul></li><li><span class=\"concept\" data-cid=\"311\">if pregnant</span> #link32 <ul><li>results in an increased risk of preterm labour, low birth weight and chorioamnionitis, late miscarriage</li><li>it was previously taught that oral metronidazole should be avoided in the first trimester and topical clindamycin used instead. Recent guidelines however recommend that oral metronidazole is used throughout pregnancy</li><li>if asymptomatic: discuss with the woman's obstetrician if treatment is indicated</li><li>if symptomatic: either oral metronidazole for 5-7 days or topical treatment. The higher, stat dose of metronidazole mentioned above is not recommended</li></ul></li></ul><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd904b.png'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd904.png'/></a></td></tr><tr><td valign='top' align='left'></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd904b.png'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><div class='imagetext'>Comparison of bacterial vaginosis and <i>Trichomonas vaginalis</i></div><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/usb002b.jpg'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/usb002.jpg'/></a></td></tr><tr><td valign='top' align='left'><span style = 'font-size:11px; color:LightGray;'>&copy; Image used on license from PathoPic</span></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/usb002b.jpg'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><div class='imagetext'>Clue cells -  epithelial cells develop a stippled appearance due to being covered with bacteria</div>",
        "notes_hash": "6bbe9a840b81afcdad0fbdc4f14af87b",
        "knowledge_graph_node_id_link": 1212,
        "concept": "Topical clindamycin is an alternative to metronidazole for patients with bacterial vaginosis",
        "concept_percentile": "94",
        "concept_colour": "rgb(30,255,0)",
        "number_attempts": "4390",
        "up_votes": "28",
        "down_votes": "47",
        "column_array": [
            0,
            "1032",
            "973",
            "1082",
            "1147",
            "156",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/RGLGy6r423s\" data-description=\"Bacterial vaginosis\" data-upvotes=\"6\" data-downvotes=\"0\" data-media=\"516\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/RGLGy6r423s/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/RGLGy6r423s\" data-description=\"Bacterial vaginosis\" data-upvotes=\"6\" data-downvotes=\"0\" data-media=\"516\">Bacterial vaginosis</a></td></tr><tr><td><span ><small>Khan Academy - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_896\" data-mediaid=\"896\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_896\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">6</span><button type=\"button\" style=\"\" id=\"media_dislike_896\" data-mediaid=\"896\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_896\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/NLef45tE3Vc\" data-description=\"Bacterial vaginosis\" data-upvotes=\"0\" data-downvotes=\"1\" data-media=\"1555\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/NLef45tE3Vc/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/NLef45tE3Vc\" data-description=\"Bacterial vaginosis\" data-upvotes=\"0\" data-downvotes=\"1\" data-media=\"1555\">Bacterial vaginosis</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2709\" data-mediaid=\"2709\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2709\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0</span><button type=\"button\" style=\"\" id=\"media_dislike_2709\" data-mediaid=\"2709\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2709\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr></table>",
        "comment_count": 5,
        "concepts_for_notes": {
            "309": {
                "concept_text": "Bacterial vaginosis: oral metronidazole",
                "concept_percentile": "65"
            },
            "310": {
                "concept_text": "Bacterial vaginosis - overgrowth of predominately <i>Gardnerella vaginalis</i>",
                "concept_percentile": "41"
            },
            "311": {
                "concept_text": "Bacterial vaginosis in pregnancy: still use oral metronidazole",
                "concept_percentile": "65"
            },
            "8946": {
                "concept_text": "Topical clindamycin is an alternative to metronidazole for patients with bacterial vaginosis",
                "concept_percentile": "94"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "2084_B_260",
        "new_question_id": "29503",
        "question_type": "0",
        "category": "2",
        "concept_id_link": "4600",
        "notes_id_link": "1_1534",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Amlodipine",
            "Bisoprolol",
            "Clopidogrel",
            "Furosemide",
            "Spironolactone",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 61-year-old man with a recent diagnosis of congestive cardiac failure and a background of psoriasis attends his GP due to a worsening of his psoriatic plaques. He recently started several medications following a consultation with his cardiologist to improve his cardiac symptoms.<br /><br />Which of the following recently started medications is most likely the cause of this man's worsening symptoms?",
            "",
            ""
        ],
        "answers": [
            "2",
            "0",
            "0"
        ],
        "notes": [
            "Beta-blockers such as bisoprolol are known to exacerbate psoriatic plaques. <br /><br />Amlodipine is a calcium channel blocker used to treat hypertension and not known to worsen psoriasis. Other anti-hypertensives such as ramipril are known to worsen psoriasis though.<br /><br />Clopidogrel is an antiplatelet agent and is not associated with worsening psoriasis symptoms. However, NSAIDs including aspirin can cause worsening of psoriasis.<br /><br />Furosemide is a loop diuretic and also has no effect on psoriasis.<br /><br />Spironolactone is an aldosterone receptor antagonist and is used as a potassium-sparing diuretic. It has no effect on psoriasis.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 61-year-old man with a recent diagnosis of congestive cardiac failure and a background of psoriasis attends his GP due to a worsening of his psoriatic plaques. He recently started several medications following a consultation with his cardiologist to improve his cardiac symptoms.<br /><br />Which of the following recently started medications is most likely the cause of this man's worsening symptoms?",
        "correct_answer": "2",
        "question_notes": "Beta-blockers such as bisoprolol are known to exacerbate psoriatic plaques. <br /><br />Amlodipine is a calcium channel blocker used to treat hypertension and not known to worsen psoriasis. Other anti-hypertensives such as ramipril are known to worsen psoriasis though.<br /><br />Clopidogrel is an antiplatelet agent and is not associated with worsening psoriasis symptoms. However, NSAIDs including aspirin can cause worsening of psoriasis.<br /><br />Furosemide is a loop diuretic and also has no effect on psoriasis.<br /><br />Spironolactone is an aldosterone receptor antagonist and is used as a potassium-sparing diuretic. It has no effect on psoriasis.",
        "answer_order": "2",
        "answer": "2",
        "title": "Psoriasis: exacerbating factors",
        "body": "The following factors may exacerbate psoriasis:<br /><ul><li>trauma</li><li><span class=\"concept\" data-cid=\"8438\">alcohol</span></li><li>drugs: <span class=\"concept\" data-cid=\"4600\">beta blockers</span>, <span class=\"concept\" data-cid=\"332\">lithium</span>, antimalarials (<span class=\"concept\" data-cid=\"8440\">chloroquine</span> and hydroxychloroquine), <span class=\"concept\" data-cid=\"8441\">NSAIDs</span> and <span class=\"concept\" data-cid=\"8442\">ACE inhibitors</span>, infliximab</li><li>withdrawal of systemic steroids</li></ul><br /><span class=\"concept\" data-cid=\"1542\">Streptococcal</span> infection may trigger guttate psoriasis.",
        "notes_hash": "5155c1972f256acf4b87f92ee1d81b9a",
        "knowledge_graph_node_id_link": 11134,
        "concept": "Beta-blockers are known to exacerbate plaque psoriasis",
        "concept_percentile": "37",
        "concept_colour": "rgb(255,188,0)",
        "number_attempts": "5735",
        "up_votes": "52",
        "down_votes": "25",
        "column_array": [
            0,
            "565",
            "2472",
            "190",
            "1237",
            "1271",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>DermNet NZ</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_29\" data-linkid=\"29\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_29\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">34</span><button type=\"button\" style=\"\" id=\"link_dislike_29\" data-linkid=\"29\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_29\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">7</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"http://www.dermnetnz.org/topics/psoriasis/\">Psoriasis</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/G1f3rlO4E40\" data-description=\"Psoriasis\" data-upvotes=\"6\" data-downvotes=\"0\" data-media=\"696\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/G1f3rlO4E40/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/G1f3rlO4E40\" data-description=\"Psoriasis\" data-upvotes=\"6\" data-downvotes=\"0\" data-media=\"696\">Psoriasis</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1208\" data-mediaid=\"1208\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1208\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">6</span><button type=\"button\" style=\"\" id=\"media_dislike_1208\" data-mediaid=\"1208\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1208\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr></table>",
        "comment_count": 8,
        "concepts_for_notes": {
            "332": {
                "concept_text": "Psoriasis: lithium may trigger an exacerbation",
                "concept_percentile": "34"
            },
            "4600": {
                "concept_text": "Beta-blockers are known to exacerbate plaque psoriasis",
                "concept_percentile": "37"
            },
            "8438": {
                "concept_text": "Psoriasis may be worsened by alcohol",
                "concept_percentile": "19"
            },
            "8440": {
                "concept_text": "Psoriasis may be worsened by chloroquine",
                "concept_percentile": "17"
            },
            "8441": {
                "concept_text": "Psoriasis may be worsened by NSAIDs",
                "concept_percentile": "29"
            },
            "8442": {
                "concept_text": "Psoriasis may be worsened by ACE inhibitors",
                "concept_percentile": "23"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "5592_B_428",
        "new_question_id": "31425",
        "question_type": "0",
        "category": "11",
        "concept_id_link": "1640",
        "notes_id_link": "1_1571",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Combined hormone replacement therapy",
            "Estradiol",
            "Levonorgestrel",
            "Medroxyprogesterone",
            "Sertraline",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 48-year-old woman visits her general practitioner with a 6-week history of unbearable hot flushes and vaginal dryness. She suspects that she is going through menopause. Her past medical history includes hypothyroidism and psoriasis. She takes regular levothyroxine and has the Mirena intrauterine system in situ. <br /><br />What is the most appropriate additional treatment to initiate for this patient?",
            "",
            ""
        ],
        "answers": [
            "2",
            "0",
            "0"
        ],
        "notes": [
            "This patient is experiencing menopausal symptoms including hot flushes and vaginal dryness, secondary to oestrogen deficiency. The aim of treating symptoms of menopause is to replace oestrogen (hormone replacement therapy). However, in a woman with a uterus, an additional source of progesterone is needed to counter the action of unopposed oestrogen on the womb, increasing the risk of endometrial hyperplasia and malignancy. This patient has the Mirena intrauterine system in situ, a coil that releases progesterone locally to act on the uterus. The Mirena coil is licensed to provide the progesterone component of hormone replacement therapy. Therefore, the only additional treatment necessary to be given to this patient is oestrogen. Of all the answers listed,  estradiol is the only option that only provides oestrogen therapy, making it the correct answer. This can be given topically and transdermally.<br /><br />Combined HRT includes both oestrogen and progesterone and is classically given orally with either a continuous or cyclical regime. It would be inappropriate to initiate this treatment as the patient would be receiving excessive amounts of progesterone as she has the Mirena coil in situ.<br /><br />Levonorgestrel is a progesterone that is typically given orally. This patient is already receiving a supply of progesterone from her Mirena coil and would be receiving an excessive dose without actually getting any oestrogen to help alleviate her menopausal symptoms.<br /><br />Medroxyprogesterone can be given by mouth or injection. Similarly to levonorgestrel, it is a progesterone and again will not provide oestrogen supplementation to the patient.<br /><br />Sertraline can be used in the treatment of vasomotor symptoms in menopausal patients. However, this patient also complains of vaginal dryness, for which sertraline is not the first-line treatment.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 48-year-old woman visits her general practitioner with a 6-week history of unbearable hot flushes and vaginal dryness. She suspects that she is going through menopause. Her past medical history includes hypothyroidism and psoriasis. She takes regular levothyroxine and has the Mirena intrauterine system in situ. <br /><br />What is the most appropriate additional treatment to initiate for this patient?",
        "correct_answer": "2",
        "question_notes": "This patient is experiencing menopausal symptoms including hot flushes and vaginal dryness, secondary to oestrogen deficiency. The aim of treating symptoms of menopause is to replace oestrogen (hormone replacement therapy). However, in a woman with a uterus, an additional source of progesterone is needed to counter the action of unopposed oestrogen on the womb, increasing the risk of endometrial hyperplasia and malignancy. This patient has the Mirena intrauterine system in situ, a coil that releases progesterone locally to act on the uterus. The Mirena coil is licensed to provide the progesterone component of hormone replacement therapy. Therefore, the only additional treatment necessary to be given to this patient is oestrogen. Of all the answers listed,  estradiol is the only option that only provides oestrogen therapy, making it the correct answer. This can be given topically and transdermally.<br /><br />Combined HRT includes both oestrogen and progesterone and is classically given orally with either a continuous or cyclical regime. It would be inappropriate to initiate this treatment as the patient would be receiving excessive amounts of progesterone as she has the Mirena coil in situ.<br /><br />Levonorgestrel is a progesterone that is typically given orally. This patient is already receiving a supply of progesterone from her Mirena coil and would be receiving an excessive dose without actually getting any oestrogen to help alleviate her menopausal symptoms.<br /><br />Medroxyprogesterone can be given by mouth or injection. Similarly to levonorgestrel, it is a progesterone and again will not provide oestrogen supplementation to the patient.<br /><br />Sertraline can be used in the treatment of vasomotor symptoms in menopausal patients. However, this patient also complains of vaginal dryness, for which sertraline is not the first-line treatment.",
        "answer_order": "2",
        "answer": "2",
        "title": "Menopause: management",
        "body": "Menopause is defined as the permanent cessation of menstruation. It is caused by the loss of follicular activity. Menopause is a clinical diagnosis usually made in primary care when a woman has not had a period for 12 months. <br /><br />Menopausal symptoms are very common and affect roughly 75% of postmenopausal women. Symptoms typically last for 7 years but may resolve quicker and in some cases take much longer. The duration and severity are also variable and may develop before the start of the menopause and in some cases may start years after the onset of menopause.  <br /><br />The CKS has very thorough and clear guidance on the management of menopause and is summarised below. <br /><br />The management of menopause can be split into three categories:<br /><ul><li>Lifestyle modifications</li><li>Hormone replacement therapy (HRT)</li><li>Non-hormone replacement therapy </li></ul><br /><br /><h5 class='notes-heading'>Management with lifestyle modifications</h5><br />Hot flushes<br /><ul><li>regular exercise, weight loss and reduce stress</li></ul><br />Sleep disturbance<br /><ul><li>avoiding late evening exercise and maintaining good sleep hygiene </li></ul><br />Mood<br /><ul><li>sleep, regular exercise and relaxation</li></ul><br />Cognitive symptoms<br /><ul><li>regular exercise and good sleep hygiene </li></ul><br /><br /><h5 class='notes-heading'>Management with HRT</h5><br />Contraindications: <br /><ul><li>Current or past breast cancer</li><li>Any oestrogen-sensitive cancer </li><li>Undiagnosed vaginal bleeding</li><li>Untreated endometrial hyperplasia </li></ul><br />Roughly 10% of women will have some form of HRT to treat their menopausal symptoms. There is a current drive by NICE to increase this number as they have found that women were previously being undertreated due to worries about increased cancer risk. If the woman has a uterus then it is important not to give unopposed oestrogens as this will increase her risk of endometrial cancer. Therefore oral or transdermal combined HRT is given.<br /><br />If the woman does not have a uterus then oestrogen alone can be given either orally or in a transdermal patch.<br /> <br />Women should be advised that the symptoms of menopause typically last for 2-5 years and that treatment with HRT brings certain risks:<br /><ul><li>Venous thromboembolism: a slight increase in risk with all forms of oral HRT. No increased risk with transdermal HRT. </li><li>Stroke: slightly increased risk with oral oestrogen HRT.</li><li>Coronary heart disease: combined HRT may be associated with a slight increase in risk.</li><li>Breast cancer: there is an increased risk with all combined HRT although the risk of dying from breast cancer is not raised. </li><li>Ovarian cancer: increased risk with all HRT.</li></ul><br /><h5 class='notes-heading'>Management with non-HRT</h5><br />Vasomotor symptoms<br /><ul><li><span class=\"concept\" data-cid=\"3065\">fluoxetine, citalopram or venlafaxine</span> </li></ul><br />Vaginal dryness<br /><ul><li>vaginal lubricant or moisturiser </li></ul><br />Psychological symptoms<br /><ul><li>self-help groups, cognitive behaviour therapy or antidepressants</li></ul><br />Urogenital symptoms<br /><ul><li>if suffering from urogenital atrophy vaginal oestrogen can be prescribed. This is appropriate if they are taking HRT or not</li><li>vaginal dryness can be treated with moisturisers and lubricants. These can be offered alongside vaginal oestrogens if required. </li></ul><br /><br /><h5 class='notes-heading'>Stopping treatment</h5><br />For vasomotor symptoms, 2-5 years of HRT may be required with regular attempts made to discontinue treatment. Vaginal oestrogen may be required long term. When stopping HRT it is important to tell women that gradually reducing HRT is effective at limiting recurrence only in the short term. In the long term, there is no difference in symptom control. <br /><br />Although menopausal symptoms can be managed mainly in primary care, there are some instances when a woman should be referred to secondary care. She should be referred to secondary care if treatment has been ineffective, if there are ongoing side effects or if there is unexplained bleeding.",
        "notes_hash": "58e05deffbd4e95e6bd21ab6aabfdf67",
        "knowledge_graph_node_id_link": 1160,
        "concept": "The Mirena intrauterine system is licensed for use as the progesterone component of HRT for 4 years",
        "concept_percentile": "79",
        "concept_colour": "rgb(107,255,0)",
        "number_attempts": "5899",
        "up_votes": "88",
        "down_votes": "50",
        "column_array": [
            0,
            "1647",
            "2514",
            "202",
            "198",
            "1338",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/hjBxRLhyd2I\" data-description=\"Menopause\" data-upvotes=\"5\" data-downvotes=\"4\" data-media=\"470\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/hjBxRLhyd2I/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/hjBxRLhyd2I\" data-description=\"Menopause\" data-upvotes=\"5\" data-downvotes=\"4\" data-media=\"470\">Menopause</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_825\" data-mediaid=\"825\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_825\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">5</span><button type=\"button\" style=\"\" id=\"media_dislike_825\" data-mediaid=\"825\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_825\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">4</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/rxZBn88iUlM\" data-description=\"Premature ovarian failure\" data-upvotes=\"2\" data-downvotes=\"2\" data-media=\"384\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/rxZBn88iUlM/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/rxZBn88iUlM\" data-description=\"Premature ovarian failure\" data-upvotes=\"2\" data-downvotes=\"2\" data-media=\"384\">Premature ovarian failure</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_658\" data-mediaid=\"658\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_658\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"media_dislike_658\" data-mediaid=\"658\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_658\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr></table>",
        "comment_count": 8,
        "concepts_for_notes": {
            "3065": {
                "concept_text": "Selective serotonin reuptake inhibitors and venlafaxine are non-hormonal methods that may help vasomotor symptoms of menopause",
                "concept_percentile": "99"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_9450",
        "new_question_id": "10285",
        "question_type": "0",
        "category": "5",
        "concept_id_link": "0",
        "notes_id_link": "1_788",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "No action, blood tests show she is immune to parvovirus",
            "No action, as she is not in the 1st trimester of pregnancy",
            "Refer to fetal medicine for further tests, bloods show a recent infection with parvovirus",
            "Refer to fetal medicine if she develops symptoms of parvovirus",
            "Refer to fetal medicine even though bloods show immunity to parvovirus ",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 15-week pregnant woman contacts her GP for advice because her 6-year-old son has recently been diagnosed with erythema infectiosum.  She is clinically well and is immune to rubella.  The GP arranges serology for parvovirus B19, which reveals parvovirus IgM positive and IgG negative.  <br /><br />What would be the most appropriate management?",
            "",
            ""
        ],
        "answers": [
            "3",
            "0",
            "0"
        ],
        "notes": [
            "Parvovirus B19 is the cause of erythema infectiosum (also known as slapped cheek).  It is a common childhood infection, with many adults being previously infected (but the infection being asymptomatic).<br /><br />Infection with parvovirus B19 is uncommon in pregnancy and the majority of pregnant women with parvovirus infection will deliver healthy babies.  However, potential complications can include hydrops fetalis and fetal death.  The risk of these complications is similar in symptomatic and asymptomatic women with parvovirus.  <br /><br />Parvovirus B19 is infectious from up to 3 weeks before the rash develops.  It is no longer infectious once the rash appears.  The risk of transmission increases with gestational age.<br /><br />Immediate serological testing for parvovirus B19 is required for all pregnant women in contact with someone with a rash consistent with parvovirus.  Significant contact is defined as face-to-face or in the same room for more than 15 minutes in the 3 weeks before the index case developed a rash.  It is also important to ensure the pregnant woman is immune to rubella.<br /><br />Blood should be tested for parvovirus B19 specific IgM and IgG.  <br /><br />IgG positive & IgM negative - shows immunity to parvovirus. Reassure, no further action.<br />IgG negative & IgM positive - non-immune.  Recent parvovirus infection in last 4 weeks.  Refer immediately for further tests/fetal medicine.<br /><br />IgG negative & IgM negative - repeat test in 4 weeks.  If both tests still negative, this confirms susceptibility, but no recent infection.  Reassure, further action required only if subsequent exposure occurs.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 15-week pregnant woman contacts her GP for advice because her 6-year-old son has recently been diagnosed with erythema infectiosum.  She is clinically well and is immune to rubella.  The GP arranges serology for parvovirus B19, which reveals parvovirus IgM positive and IgG negative.  <br /><br />What would be the most appropriate management?",
        "correct_answer": "3",
        "question_notes": "Parvovirus B19 is the cause of erythema infectiosum (also known as slapped cheek).  It is a common childhood infection, with many adults being previously infected (but the infection being asymptomatic).<br /><br />Infection with parvovirus B19 is uncommon in pregnancy and the majority of pregnant women with parvovirus infection will deliver healthy babies.  However, potential complications can include hydrops fetalis and fetal death.  The risk of these complications is similar in symptomatic and asymptomatic women with parvovirus.  <br /><br />Parvovirus B19 is infectious from up to 3 weeks before the rash develops.  It is no longer infectious once the rash appears.  The risk of transmission increases with gestational age.<br /><br />Immediate serological testing for parvovirus B19 is required for all pregnant women in contact with someone with a rash consistent with parvovirus.  Significant contact is defined as face-to-face or in the same room for more than 15 minutes in the 3 weeks before the index case developed a rash.  It is also important to ensure the pregnant woman is immune to rubella.<br /><br />Blood should be tested for parvovirus B19 specific IgM and IgG.  <br /><br />IgG positive & IgM negative - shows immunity to parvovirus. Reassure, no further action.<br />IgG negative & IgM positive - non-immune.  Recent parvovirus infection in last 4 weeks.  Refer immediately for further tests/fetal medicine.<br /><br />IgG negative & IgM negative - repeat test in 4 weeks.  If both tests still negative, this confirms susceptibility, but no recent infection.  Reassure, further action required only if subsequent exposure occurs.",
        "answer_order": "3",
        "answer": "3",
        "title": "Parvovirus B19",
        "body": "Parvovirus B19 is a DNA virus which causes a variety of clinical presentations. It was identified in the 1980's as the cause of erythema infectiosum<br /><br /><h5 class='notes-heading'>Erythema infectiosum (also known as fifth disease or 'slapped-cheek syndrome')</h5><br />The illness may consist of a mild feverish illness which is hardly noticeable. However, in others there is a noticeable rash which appears after a few days. The rose-red rash makes the cheeks appear bright red, hence the name 'slapped cheek syndrome'. The rash may spread to the rest of the body but unlike many other rashes, it only rarely involves the palms and soles.<br /><br />The child begins to feel better as the rash appears and the rash usually peaks after a week and then fades. The rash is unusual in that for some months afterwards, a warm bath, sunlight, heat or fever will trigger a recurrence of the bright red cheeks and the rash itself. Most children recover and need no specific treatment. <span class=\"concept\" data-cid=\"8105\">School exclusion is unnecessary as the child is not infectious once the rash emerges</span>. In adults, the virus may cause acute arthritis.<br /><br />Be aware that the virus can affect an unborn baby in the first 20 weeks of pregnancy. If a woman is exposed early in pregnancy (before 20 weeks) she should seek prompt advice from whoever is giving her antenatal care as <span class=\"concept\" data-cid=\"7262\">maternal IgM and IgG</span> will need to be checked. It is spread by the respiratory route and a person is infectious 3 to 5 days before the appearance of the rash. Children are no longer infectious once the rash appears and there is no specific treatment.<br /><br />The child need not be excluded from school as they are no longer infectious by the time the rash occurs.<br /><br /><h5 class='notes-heading'>Other presentations</h5><br />Other presentations include:<br /><ul><li>asymptomatic</li><li>pancytopaenia in immunosuppressed patients</li><li><span class=\"concept\" data-cid=\"3608\">aplastic crises e.g. in sickle-cell disease</span><ul><li>parvovirus B19 suppresses erythropoiesis for about a week so aplastic anaemia is rare unless there is a chronic haemolytic anaemia</li></ul></li><li>hydrops fetalis<ul><li>parvovirus B19 in pregnant women can cross the placenta in pregnant women</li><li><span class=\"concept\" data-cid=\"11583\">this causes severe anaemia due to viral suppression of fetal erythropoiesis &rarr; heart failure secondary to severe anaemia &rarr; the accumulation of fluid in fetal serous cavities</span> (e.g. ascites, pleural and pericardial effusions)</li><li>treated with <span class=\"concept\" data-cid=\"8604\">intrauterine blood transfusions</span></li></ul></li></ul>",
        "notes_hash": "d27b0a10e36fcc851a73a47a3c3d9b59",
        "knowledge_graph_node_id_link": 0,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "4008",
        "up_votes": "17",
        "down_votes": "17",
        "column_array": [
            0,
            "589",
            "120",
            "2777",
            "218",
            "304",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>DermNet NZ</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_453\" data-linkid=\"453\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_453\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">8</span><button type=\"button\" style=\"\" id=\"link_dislike_453\" data-linkid=\"453\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_453\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">7</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"http://www.dermnetnz.org/viral/fifth.html\">Fifth disease</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/QGikLAy-bqo\" data-description=\"Parvovirus B19\" data-upvotes=\"4\" data-downvotes=\"1\" data-media=\"1125\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/QGikLAy-bqo/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/QGikLAy-bqo\" data-description=\"Parvovirus B19\" data-upvotes=\"4\" data-downvotes=\"1\" data-media=\"1125\">Parvovirus B19</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1946\" data-mediaid=\"1946\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1946\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">4</span><button type=\"button\" style=\"\" id=\"media_dislike_1946\" data-mediaid=\"1946\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1946\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr></table>",
        "comment_count": 9,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    },
    {
        "question_id": "31935_B_28",
        "new_question_id": "56051",
        "question_type": "0",
        "category": "6",
        "concept_id_link": "9986",
        "notes_id_link": "1_2749",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Anterior talofibular ligament sprain",
            "Deltoid ligament sprain",
            "Lateral malleolus fracture",
            "Posterior talofibular ligament sprain",
            "Syndesmotic sprain",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 29-year-old woman presents to the emergency department after injuring her right ankle while playing tennis. She describes jumping to hit a volley, landing on her foot awkwardly, and feeling her ankle roll over her foot causing excessive inversion. She immediately experienced a sharp pain on the outside of her ankle. There is noticeable swelling and bruising around the ankle but she can walk on it, though it causes her pain.<br /><br />What is the most likely diagnosis?",
            "",
            ""
        ],
        "answers": [
            "1",
            "0",
            "0"
        ],
        "notes": [
            "<b> Anterior talofibular ligament sprain </b> is correct. The mechanism of injury here is an inversion, in which the anterior talofibular ligament (ATFL) is the most likely sprained ligament. The ATFL is involved in around 90% of all ankle sprains, making it the most commonly injured ligament. This often leads to pain and swelling, though patients are still usually able to bear weight on the joint despite pain.<br /><br /><b> Deltoid ligament sprain </b> is incorrect. The deltoid ligament, located on the medial side of the ankle, is more commonly injured in eversion injuries, where the ankle rolls outward, which is not the case here.<br /><br /><b> Lateral malleolus fracture </b> is incorrect. This is less likely in this scenario because the patient can still bear weight on the painful ankle. However, while the ability to bear weight may reduce the likelihood of a fracture, it does not entirely rule it out. If there is any suspicion of a fracture, consider radiographs as per Ottawa ankle rules.<br /><br /><b> Posterior talofibular ligament sprain </b> is incorrect. The PTFL is typically injured in severe trauma or high-impact injuries rather than a simple inversion injury as described. The most common ligament to be damaged in the ankle is the ATFL.<br /><br /><b> Syndesmotic sprain </b> is incorrect. In the ankle, the syndesmosis is the fibrous joint connecting the tibia and fibula just above the ankle joint, providing stability and maintaining alignment between the two bones. Syndesmotic injuries are rare and the mechanism involves external rotation of the foot, not inversion as described here.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 29-year-old woman presents to the emergency department after injuring her right ankle while playing tennis. She describes jumping to hit a volley, landing on her foot awkwardly, and feeling her ankle roll over her foot causing excessive inversion. She immediately experienced a sharp pain on the outside of her ankle. There is noticeable swelling and bruising around the ankle but she can walk on it, though it causes her pain.<br /><br />What is the most likely diagnosis?",
        "correct_answer": "1",
        "question_notes": "<b> Anterior talofibular ligament sprain </b> is correct. The mechanism of injury here is an inversion, in which the anterior talofibular ligament (ATFL) is the most likely sprained ligament. The ATFL is involved in around 90% of all ankle sprains, making it the most commonly injured ligament. This often leads to pain and swelling, though patients are still usually able to bear weight on the joint despite pain.<br /><br /><b> Deltoid ligament sprain </b> is incorrect. The deltoid ligament, located on the medial side of the ankle, is more commonly injured in eversion injuries, where the ankle rolls outward, which is not the case here.<br /><br /><b> Lateral malleolus fracture </b> is incorrect. This is less likely in this scenario because the patient can still bear weight on the painful ankle. However, while the ability to bear weight may reduce the likelihood of a fracture, it does not entirely rule it out. If there is any suspicion of a fracture, consider radiographs as per Ottawa ankle rules.<br /><br /><b> Posterior talofibular ligament sprain </b> is incorrect. The PTFL is typically injured in severe trauma or high-impact injuries rather than a simple inversion injury as described. The most common ligament to be damaged in the ankle is the ATFL.<br /><br /><b> Syndesmotic sprain </b> is incorrect. In the ankle, the syndesmosis is the fibrous joint connecting the tibia and fibula just above the ankle joint, providing stability and maintaining alignment between the two bones. Syndesmotic injuries are rare and the mechanism involves external rotation of the foot, not inversion as described here.",
        "answer_order": "1",
        "answer": "1",
        "title": "Ankle sprain",
        "body": "The bony components of the ankle joint include the distal tibia and fibula and the superior aspect of the talus. Their configuration is such that they form a mortise, with the body of the talus acting as the tenon. This arrangement is secured by a number of ligamentous structures: <br /><ul><li>The syndesmosis binds the distal tibia and fibula together (another example of a syndesmosis is the distal radio-ulnar joint). It is composed of the anterior inferior tibiofibular ligament (AITFL), posterior inferior tibiofibular ligament (PITFL), interosseous ligament (IOL) and the interosseous membrane.</li><li>The distal fibular is secured to the to the talus by the anterior and posterior talofibular ligaments (ATFL and PTFL) and to the calcaneus by the calcaneofibular ligament. These ligaments are sometimes referred to collectively as the lateral collateral ligaments.</li><li>The distal tibia is secured to the talus by the deltoid ligament, in view of its triangular shape.</li></ul><br />A sprain is a stretching, partial or complete tear of a ligament. In the ankle, this can be divided into high ankle sprains involving the syndesmosis and low ankle sprains involving the lateral collateral ligaments. <br /><br /><h5 class='notes-heading'>Low ankle sprains</h5><br />Presentation:<br /><ul><li>most common (>90%) with <span class=\"concept\" data-cid=\"9986\">injury to the ATFL</span> the most common offender</li><li><span class=\"concept\" data-cid=\"9836\">inversion injury most common mechanism</span></li><li>pain, swelling, tenderness over affected ligaments and sometimes bruising</li><li>patients usually able to weight bear unless severe</li><li>they can be classified as follows</li></ul><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th>Grade</th><th>Ligament disruption</th><th>Bruising and swelling</th><th>Pain on weight bearing</th></tr></thead><tbody><tr><td>Grade I (mild)</td><td>Stretch or micro tear</td><td>minimal</td><td>normal</td></tr><tr><td>Grade II (moderate)</td><td>Partial tear</td><td>moderate</td><td>minimal</td></tr><tr><td>Grade III (severe)</td><td>Complete tear</td><td>Severe</td><td>Severe</td></tr></tbody></table></div><br />Investigation:<br /><ul><li>Radiographs should be done according to the Ottawa ankle rules as 15% of sprains are associated with a fracture.</li><li>MRI if persistent pain and useful for evaluating perineal tendons. </li></ul><br />Treatment:<br /><ul><li>Non-operative with rest, ice, compression and elevation (the so-called RICE protocol).</li><li>Occasionally a removable orthosis, cast and/or crutches may be required for short-term symptom relief.</li><li>If symptoms fail to settle or there is significant joint instability then an MRI and surgical intervention may be contemplated, but this is rare.</li></ul><br /><h5 class='notes-heading'>High ankle sprains</h5><br />Presentation:<br /><ul><li>Injuries to the syndesmosis are rare (about 0.5%) and severe.</li><li>The mechanism of injury is usually external rotation of the foot causing the talus to push the fibula laterally.</li><li>Patients frequently find weight-bearing painful in comparison to low ankle sprains.</li><li>Pain when the tibia and fibula are squeezed together at the level of the mid-calf (Hopkin's squeeze test).</li></ul><br /> Investigations:<br /><ul><li>Radiographs may show widening of the tibiofibular joint (diastasis) or ankle mortise.</li><li>MRI if high suspicion of syndesmotic injury, but normal plain films.</li></ul><br /> Treatment:<br /><ul><li>If no diastasis then non-weight-bearing orthosis or cast until pain subsides.</li><li>If diastasis or failed non-operative management then operative fixation is usually warranted.</li></ul><br />Isolated injuries to the deltoid ligament are rare as they are frequently associated with a fracture and one should always be on the lookout for Maisonneuve fracture of the proximal fibula. Provided the ankle mortise is anatomically reduced then treatment can be as per a low ankle sprain, if not then reduction and fixation may be warranted. ",
        "notes_hash": "0cd6d82ca3e3d010d33da4c89f43c68c",
        "knowledge_graph_node_id_link": 1388,
        "concept": "The anterior talofibular ligament is the most commonly sprained ligament in inversion injuries of the ankle",
        "concept_percentile": "78",
        "concept_colour": "rgb(112,255,0)",
        "number_attempts": "4527",
        "up_votes": "5",
        "down_votes": "2",
        "column_array": [
            0,
            "2400",
            "417",
            "642",
            "830",
            "238",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "",
        "comment_count": 1,
        "concepts_for_notes": {
            "9986": {
                "concept_text": "The anterior talofibular ligament is the most commonly sprained ligament in inversion injuries of the ankle",
                "concept_percentile": "78"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "16300_B_1048",
        "new_question_id": "34525",
        "question_type": "0",
        "category": "11",
        "concept_id_link": "11496",
        "notes_id_link": "1_1701",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Clomifene",
            "Combined oral contraceptive pill",
            "Elagolix",
            "Laparoscopic excision",
            "Leuprorelin",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 30-year-old woman presents with ongoing, cyclical pain around the time of her periods. The pain starts several days before the period itself and can last until several days after. She also experiences pain during sexual intercourse, particularly with deep penetration.<br /><br />Examination demonstrated tender nodularity in the posterior fornix.<br /><br />The patient has already tried paracetamol and ibuprofen, but these are no longer effective. <br /><br />What is the next most appropriate step?",
            "",
            ""
        ],
        "answers": [
            "2",
            "0",
            "0"
        ],
        "notes": [
            "This patient has endometriosis, as evidenced by her symptoms and findings on examination. First-line treatment involves the use of simple analgesia. As this is no longer effective, the next step is to use either progestogens or the <b>combined oral contraceptive pill</b>. Hormonal treatments are generally effective at controlling endometriosis-related pain.<br /><br /><b>Clomifene</b> is used to induce ovulation in a number of conditions. While endometriosis can affect fertility and clomifene may be used for this aspect, by an experienced fertility doctor, it would not be the next step in pain management.<br /><br /><b>Elagolix</b> is a relatively new gonadotropin-releasing hormone antagonist. It is licensed in the USA for endometriosis-related pain. It is not widely used in the UK currently and so the next most appropriate option remains the combined contraceptive pill.<br /><br /><b>Laparoscopic excision</b> is further down the line, as surgery carries significant risks. The next step, after simple analgesia, is the use of hormonal options.<br /><br /><b>Leuprorelin</b> is a gonadotropin-releasing hormone agonist. Whilst effective for the control of endometriosis-related pain, it is prescribed by specialists and would not be the next step after simple analgesia.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 30-year-old woman presents with ongoing, cyclical pain around the time of her periods. The pain starts several days before the period itself and can last until several days after. She also experiences pain during sexual intercourse, particularly with deep penetration.<br /><br />Examination demonstrated tender nodularity in the posterior fornix.<br /><br />The patient has already tried paracetamol and ibuprofen, but these are no longer effective. <br /><br />What is the next most appropriate step?",
        "correct_answer": "2",
        "question_notes": "This patient has endometriosis, as evidenced by her symptoms and findings on examination. First-line treatment involves the use of simple analgesia. As this is no longer effective, the next step is to use either progestogens or the <b>combined oral contraceptive pill</b>. Hormonal treatments are generally effective at controlling endometriosis-related pain.<br /><br /><b>Clomifene</b> is used to induce ovulation in a number of conditions. While endometriosis can affect fertility and clomifene may be used for this aspect, by an experienced fertility doctor, it would not be the next step in pain management.<br /><br /><b>Elagolix</b> is a relatively new gonadotropin-releasing hormone antagonist. It is licensed in the USA for endometriosis-related pain. It is not widely used in the UK currently and so the next most appropriate option remains the combined contraceptive pill.<br /><br /><b>Laparoscopic excision</b> is further down the line, as surgery carries significant risks. The next step, after simple analgesia, is the use of hormonal options.<br /><br /><b>Leuprorelin</b> is a gonadotropin-releasing hormone agonist. Whilst effective for the control of endometriosis-related pain, it is prescribed by specialists and would not be the next step after simple analgesia.",
        "answer_order": "2",
        "answer": "2",
        "title": "Endometriosis",
        "body": "Endometriosis is a common condition characterised by the growth of ectopic endometrial tissue outside of the uterine cavity. Around 10% of women of reproductive age have a degree of endometriosis.<br /><br /><span class=\"concept\" data-cid=\"986\">Clinical features</span><br /><ul><li>chronic pelvic pain</li><li>secondary dysmenorrhoea<ul><li>pain often starts days before bleeding</li></ul></li><li>deep dyspareunia </li><li>subfertility</li><li>non-gynaecological: urinary symptoms e.g. dysuria, urgency, haematuria. Dyschezia (painful bowel movements)</li><li>on pelvic examination reduced organ mobility, tender nodularity in the posterior vaginal fornix and visible vaginal endometriotic lesions may be seen</li></ul><br />Investigation<br /><ul><li><b><span class=\"concept\" data-cid=\"985\">laparoscopy</span> is the gold-standard investigation</b></li><li>there is little role for investigation in primary care (e.g. ultrasound)- if the symptoms are significant the patient should be referred for a definitive diagnosis </li></ul><br />Management depends on clinical features - there is poor correlation between laparoscopic findings and severity of symptoms. NICE published guidelines in 2017:<br /><ul><li><span class=\"concept\" data-cid=\"11495\"><b>NSAIDs and/or paracetamol</b></span> are the recommended first-line treatments for symptomatic relief</li><li>if analgesia doesn't help then hormonal treatments such as the <span class=\"concept\" data-cid=\"11496\"><b>combined oral contraceptive pill or progestogens</b></span> e.g. medroxyprogesterone acetate should be tried</li></ul><br />If analgesia/hormonal treatment does not improve symptoms, or if fertility is a priority, the patient should be referred to secondary care. Secondary treatments include:<br /><ul><li><span class=\"concept\" data-cid=\"11655\">GnRH analogues</span> - said to induce a 'pseudomenopause' due to the low oestrogen levels</li><li>drug therapy unfortunately does not seem to have a significant impact on fertility rates</li><li>surgery<ul><li>this may be an option for women who have not responded to conventional medical treatment</li><li><span class=\"concept\" data-cid=\"11974\">for women who are trying to conceive, NICE recommend laparoscopic excision or ablation of endometriosis</span> plus adhesiolysis as this has been shown to improve the chances of conception. Ovarian cystectomy (for endometriomas) is also recommended</li></ul></li></ul>",
        "notes_hash": "f50d9c61511fa098e409ec778cb9dbef",
        "knowledge_graph_node_id_link": 1040,
        "concept": "If analgesia doesn't help endometriosis then the combined oral contraceptive pill or a progestogen should be tried",
        "concept_percentile": "87",
        "concept_colour": "rgb(66,255,0)",
        "number_attempts": "5364",
        "up_votes": "21",
        "down_votes": "37",
        "column_array": [
            0,
            "279",
            "3781",
            "81",
            "1036",
            "187",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1215\" data-linkid=\"1215\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1215\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">8</span><button type=\"button\" style=\"\" id=\"link_dislike_1215\" data-linkid=\"1215\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1215\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">8</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng73/chapter/Recommendations\">2017 Endometriosis: diagnosis and management</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/watch?v=FFW--bvozsE\" data-description=\"Endometriosis\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"327\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/FFW--bvozsE/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/watch?v=FFW--bvozsE\" data-description=\"Endometriosis\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"327\">Endometriosis</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_554\" data-mediaid=\"554\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_554\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0</span><button type=\"button\" style=\"\" id=\"media_dislike_554\" data-mediaid=\"554\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_554\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/dsKj5hKR9HU\" data-description=\"Understanding Endometriosis\" data-upvotes=\"7\" data-downvotes=\"1\" data-media=\"611\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/dsKj5hKR9HU/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/dsKj5hKR9HU\" data-description=\"Understanding Endometriosis\" data-upvotes=\"7\" data-downvotes=\"1\" data-media=\"611\">Understanding Endometriosis</a></td></tr><tr><td><span ><small>Zero to Finals - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1038\" data-mediaid=\"1038\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1038\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">7</span><button type=\"button\" style=\"\" id=\"media_dislike_1038\" data-mediaid=\"1038\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1038\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/3rwO0OhRnn8\" data-description=\"Endometriosis\" data-upvotes=\"2\" data-downvotes=\"2\" data-media=\"899\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/3rwO0OhRnn8/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/3rwO0OhRnn8\" data-description=\"Endometriosis\" data-upvotes=\"2\" data-downvotes=\"2\" data-media=\"899\">Endometriosis</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1564\" data-mediaid=\"1564\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1564\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"media_dislike_1564\" data-mediaid=\"1564\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1564\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr></table>",
        "comment_count": 6,
        "concepts_for_notes": {
            "985": {
                "concept_text": "Laparoscopy is the gold-standard investigation for patients with suspected endometriosis",
                "concept_percentile": "58"
            },
            "986": {
                "concept_text": "The classic symptoms of endometriosis are pelvic pain, dysmenorrhoea, dyspareunia and subfertility",
                "concept_percentile": "64"
            },
            "11495": {
                "concept_text": "NSAIDs and/or paracetamol are the recommended first-line treatments for endometriosis",
                "concept_percentile": "98"
            },
            "11496": {
                "concept_text": "If analgesia doesn't help endometriosis then the combined oral contraceptive pill or a progestogen should be tried",
                "concept_percentile": "87"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "16718_B_1177",
        "new_question_id": "27655",
        "question_type": "0",
        "category": "9",
        "concept_id_link": "9510",
        "notes_id_link": "1_1237",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Citalopram",
            "Fluoxetine",
            "Gentamicin",
            "Sertraline",
            "Spironolactone",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 55-year-old woman presents to the emergency department with palpitations, dizziness, and lightheadedness. The team performs an ECG, that shows torsades de pointes. <br /><br />Which one of the following drugs is most likely to have caused the cardiac abnormality?",
            "",
            ""
        ],
        "answers": [
            "1",
            "0",
            "0"
        ],
        "notes": [
            "Citalopram is a selective serotonin reuptake inhibitor (SSRI) used for the treatment of a major depressive disorder. The Medicines and Healthcare products Regulatory Agency (MHRA) released a warning on the use of citalopram in 2011. It should not be used in patients who already have issues with long-QT syndrome. This is because it is the most likely SSRI to cause QT prolongation and torsades de pointes. <br /><br />Fluoxetine and sertraline are other SSRIs that can cause a prolonged QT. However, citalopram is more commonly associated with it. For this reason, the MHRA released the warning about citalopram in 2011.   <br /><br />Gentamicin is a bactericidal antibiotic that inhibits the 30S subunit of the bacterial ribosome. It has not been shown to cause QT prolongation or torsades de pointes. <br /><br />Sertraline is another SSRI and can cause prolonged QT but citalopram is more commonly associated with it.<br /><br />Spironolactone is an aldosterone antagonist which acts in the cortical collecting duct. It can cause hyperkalemia, whilst torsades de pointes are associated with hypokalemia.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 55-year-old woman presents to the emergency department with palpitations, dizziness, and lightheadedness. The team performs an ECG, that shows torsades de pointes. <br /><br />Which one of the following drugs is most likely to have caused the cardiac abnormality?",
        "correct_answer": "1",
        "question_notes": "Citalopram is a selective serotonin reuptake inhibitor (SSRI) used for the treatment of a major depressive disorder. The Medicines and Healthcare products Regulatory Agency (MHRA) released a warning on the use of citalopram in 2011. It should not be used in patients who already have issues with long-QT syndrome. This is because it is the most likely SSRI to cause QT prolongation and torsades de pointes. <br /><br />Fluoxetine and sertraline are other SSRIs that can cause a prolonged QT. However, citalopram is more commonly associated with it. For this reason, the MHRA released the warning about citalopram in 2011.   <br /><br />Gentamicin is a bactericidal antibiotic that inhibits the 30S subunit of the bacterial ribosome. It has not been shown to cause QT prolongation or torsades de pointes. <br /><br />Sertraline is another SSRI and can cause prolonged QT but citalopram is more commonly associated with it.<br /><br />Spironolactone is an aldosterone antagonist which acts in the cortical collecting duct. It can cause hyperkalemia, whilst torsades de pointes are associated with hypokalemia.",
        "answer_order": "1",
        "answer": "1",
        "title": "Selective serotonin reuptake inhibitors",
        "body": "Selective serotonin reuptake inhibitors (SSRIs) are considered first-line treatment for the majority of patients with depression. <br /><ul><li>citalopram (although see below re: QT interval) and fluoxetine are currently the preferred SSRIs</li><li><span class=\"concept\" data-cid=\"2415\">sertraline is useful post myocardial infarction</span> as there is more evidence for its safe use in this situation than other antidepressants</li><li>SSRIs should be used with caution in <span class=\"concept\" data-cid=\"243\">children and adolescents. Fluoxetine is the drug of choice</span> when an antidepressant is indicated</li></ul><br />Adverse effects<br /><ul><li>gastrointestinal symptoms are the most common side-effect</li><li>there is an increased risk of gastrointestinal bleeding in patients taking SSRIs. A proton pump inhibitor should be prescribed if a patient is also taking a NSAID</li><li>patients should be counselled to be vigilant for increased anxiety and agitation after starting a SSRI</li><li>fluoxetine and paroxetine have a higher propensity for drug interactions</li></ul><br /><span class=\"concept\" data-cid=\"9510\">Citalopram and the QT interval</span><br /><ul><li>the Medicines and Healthcare products Regulatory Agency (MHRA) released a warning on the use of citalopram in 2011</li><li>it advised that citalopram and escitalopram are associated with dose-dependent QT interval prolongation and should not be used in those with: congenital long QT syndrome; known pre-existing QT interval prolongation; or in combination with other medicines that prolong the QT interval</li><li>the maximum daily dose is now 40 mg for adults; 20 mg for patients older than 65 years; and 20 mg for those with hepatic impairment</li></ul><br />Interactions<br /><ul><li><span class=\"concept\" data-cid=\"242\">NSAIDs</span>: NICE guidelines advise 'do not normally offer SSRIs', but if given co-prescribe a proton pump inhibitor</li><li><span class=\"concept\" data-cid=\"2414\">warfarin</span> / heparin: NICE guidelines recommend avoiding SSRIs and considering mirtazapine</li><li>aspirin</li><li><span class=\"concept\" data-cid=\"8281\">triptans</span> - increased risk of serotonin syndrome</li><li><span class=\"concept\" data-cid=\"1140\">monoamine oxidase inhibitors (MAOIs)</span> - increased risk of serotonin syndrome</li></ul><br />Following the initiation of antidepressant therapy patients should normally be reviewed by a doctor after 2 weeks. For <span class=\"concept\" data-cid=\"11945\">patients under the age of 25 years or at increased risk of suicide should be reviewed after 1 week</span>. If a patient makes a good response to antidepressant therapy they should continue on treatment for at least <span class=\"concept\" data-cid=\"1143\">6 months</span> after remission as this reduces the risk of relapse. <br /><br />When stopping a SSRI the dose should be gradually reduced over a <span class=\"concept\" data-cid=\"8280\">4 week</span> period (this is not necessary with fluoxetine). <span class=\"concept\" data-cid=\"241\">Paroxetine has a higher incidence of discontinuation symptoms</span>.<br /><br /><span class=\"concept\" data-cid=\"1144\">Discontinuation symptoms</span><br /><ul><li>increased mood change</li><li>restlessness</li><li>difficulty sleeping</li><li>unsteadiness</li><li>sweating</li><li><span class=\"concept\" data-cid=\"8279\">gastrointestinal symptoms: pain, cramping, diarrhoea, vomiting</span></li><li>paraesthesia</li></ul><br />SSRIs and pregnancy<br />    -    BNF says to weigh up benefits and risk when deciding whether to use in pregnancy.<br />    -    Use during the first trimester gives a small increased risk of congenital heart defects<br />    -    Use during the third trimester can result in <span class=\"concept\" data-cid=\"2681\">persistent pulmonary hypertension</span> of the newborn<br />    -    <span class=\"concept\" data-cid=\"2684\">Paroxetine has an increased risk of congenital malformations</span>, particularly in the first trimester",
        "notes_hash": "68dbd8a42b65755d61d01a8b61c29a88",
        "knowledge_graph_node_id_link": 10859,
        "concept": "Citalopram is the most likely SSRI to lead to QT prolongation and Torsades de pointes",
        "concept_percentile": "96",
        "concept_colour": "rgb(20,255,0)",
        "number_attempts": "4948",
        "up_votes": "22",
        "down_votes": "10",
        "column_array": [
            0,
            "3611",
            "521",
            "213",
            "341",
            "262",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_803\" data-linkid=\"803\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_803\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">36</span><button type=\"button\" style=\"\" id=\"link_dislike_803\" data-linkid=\"803\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_803\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">41</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng222/chapter/Recommendations\">2022 Depression in adults: treatment and management</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/T25jvLC6X0w\" data-description=\"Antidepressants\" data-upvotes=\"9\" data-downvotes=\"3\" data-media=\"631\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/T25jvLC6X0w/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/T25jvLC6X0w\" data-description=\"Antidepressants\" data-upvotes=\"9\" data-downvotes=\"3\" data-media=\"631\">Antidepressants</a></td></tr><tr><td><span ><small>Speed Pharmacology - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1082\" data-mediaid=\"1082\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1082\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">9</span><button type=\"button\" style=\"\" id=\"media_dislike_1082\" data-mediaid=\"1082\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1082\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">3</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/4X5nqkEBmTo\" data-description=\"Antidepressants Pharmacology\" data-upvotes=\"3\" data-downvotes=\"5\" data-media=\"313\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/4X5nqkEBmTo/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/4X5nqkEBmTo\" data-description=\"Antidepressants Pharmacology\" data-upvotes=\"3\" data-downvotes=\"5\" data-media=\"313\">Antidepressants Pharmacology</a></td></tr><tr><td><span ><small>Soton Brain Hub - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_533\" data-mediaid=\"533\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_533\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">3</span><button type=\"button\" style=\"\" id=\"media_dislike_533\" data-mediaid=\"533\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_533\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">5</span></td></tr></table>",
        "comment_count": 2,
        "concepts_for_notes": {
            "242": {
                "concept_text": "SSRI + NSAID = GI bleeding risk - give a PPI",
                "concept_percentile": "78"
            },
            "243": {
                "concept_text": "Fluoxetine is the SSRI of choice in children and adolescents",
                "concept_percentile": "85"
            },
            "1140": {
                "concept_text": "SSRIs and MAOIs should never be combined as there is a risk of serotonin syndrome",
                "concept_percentile": "94"
            },
            "1143": {
                "concept_text": "Antidepressants should be continued for at least 6 months after remission of symptoms to decrease risk of relapse",
                "concept_percentile": "55"
            },
            "1144": {
                "concept_text": "Dizziness, electric shock sensations and anxiety are symptoms of SSRI discontinuation syndrome\r\n",
                "concept_percentile": "96"
            },
            "2415": {
                "concept_text": "Sertraline is the SSRI of choice post myocardial infarction",
                "concept_percentile": "76"
            },
            "2684": {
                "concept_text": "Paroxetine use in pregnancy - can lead to increased risk of congenital malformations",
                "concept_percentile": "69"
            },
            "8279": {
                "concept_text": "Gastrointestinal side-effects such as diarrhoea are seen in SSRI discontinuation syndrome",
                "concept_percentile": "84"
            },
            "8281": {
                "concept_text": "Triptans should be avoided in patients taking a SSRI",
                "concept_percentile": "85"
            },
            "9510": {
                "concept_text": "Citalopram is the most likely SSRI to lead to QT prolongation and Torsades de pointes",
                "concept_percentile": "96"
            },
            "11945": {
                "concept_text": "Patients \u2264  25 years who have been started on an SSRI should be reviewed after 1 week",
                "concept_percentile": "96"
            }
        },
        "optimisation_reason": ""
    }
]